RAFAEL HOLDINGS, INC. Available-for-sale Securities
RAFAEL HOLDINGS, INC. (RFL) had Available-for-sale Securities of $5.27 million as of 2021-07-31, per its 10-K filed 2021-10-18.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2021-10-18
- 2021-07-31: Available-for-sale Securities $5.27M.
- 2021-04-30: Available-for-sale Securities $9.68M.
- 2021-01-31: Available-for-sale Securities $8.94M.
- 2020-10-31: Available-for-sale Securities $6.45M.
| Period end | Available-for-sale Securities |
|---|---|
| 2021-07-31 | $5.27M 10-K · filed 2021-10-18 |
| 2021-04-30 | $9.68M 10-Q · filed 2021-06-14 |
| 2021-01-31 | $8.94M 10-Q · filed 2021-03-17 |
| 2020-10-31 | $6.45M 10-Q · filed 2020-12-15 |
| 2020-07-31 | $7.51M 10-K · filed 2021-10-18 |
| 2020-04-30 | $5.62M 10-Q · filed 2020-06-09 |
| 2020-01-31 | $5.64M 10-Q · filed 2020-03-05 |
| 2019-10-31 | $5.09M 10-Q · filed 2019-12-09 |
| 2019-07-31 | $5.13M 10-K · filed 2020-10-29 |
| 2019-04-30 | $4.63M 10-Q · filed 2019-06-05 |
| 2019-01-31 | $4.17M 10-Q · filed 2019-03-12 |
| 2018-10-31 | $32.27M 10-Q · filed 2018-12-10 |
| 2018-07-31 | $36.82M 10-K · filed 2019-10-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |